Clinical Trials Directory

Trials / Unknown

UnknownNCT03638245

Evaluation of the Fetal MPI in Abnormal Cardiotocography Cases in 3rd Trimester of Pregnancy and Fetal Outcome.

Evaluation of the Fetal Myocardial Performance Index in Abnormal Cardiotocography Cases in 3rd Trimester of Pregnancy and Fetal Outcome

Status
Unknown
Phase
Study type
Observational
Enrollment
148 (estimated)
Sponsor
Ali Mohamed AbdEl-Halim Ali Mehanna · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

The study will focus in evaluation of fetal cardiac function by using myocardial performance index in fetuses with abnormal cardiotocography in 3rd trimester.

Detailed description

The study will focus in evaluation of fetal cardiac function by using myocardial performance index in fetuses with abnormal cardiotocography in 3rd trimester. Study Hypothesis: In women with non reassuring fetal cardiotocography, myocardial performance index may predict fetal distress accurately. Study Question: In pregnant women in the third trimester with abnormal cardiotocography, Does myocardial performance index predict fetal distress accurately? Study Objectives: This study aims to assess the accuracy of myocardial performance index in predicting fetal distress in pregnant women with non reassuring cardiotocography in third trimester.

Conditions

Timeline

Start date
2018-10-10
Primary completion
2019-03-10
Completion
2020-03-10
First posted
2018-08-20
Last updated
2018-08-20

Source: ClinicalTrials.gov record NCT03638245. Inclusion in this directory is not an endorsement.

Evaluation of the Fetal MPI in Abnormal Cardiotocography Cases in 3rd Trimester of Pregnancy and Fetal Outcome. (NCT03638245) · Clinical Trials Directory